Philadelphia, PA, United States of America

Stephani Velasquez

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Temple University. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Stephani Velasquez

Introduction

Stephani Velasquez is an accomplished inventor based in Philadelphia, PA. She has made significant contributions to the field of biomedical research, particularly in the modulation of metabolic pathways for disease treatment. Her innovative work has the potential to impact various therapeutic approaches.

Latest Patents

Stephani Velasquez holds a patent titled "Modulation of NAD+ metabolic pathways for treatment of disease." This invention encompasses compositions and methods for regulating the kynurenine to tryptophan ratio, NAD+ level, and CD16 expression for the treatment of diseases. She has 1 patent to her name, showcasing her dedication to advancing medical science.

Career Highlights

Velasquez is affiliated with Temple University, where she conducts her research and develops her inventions. Her work at the university has allowed her to explore innovative solutions to complex health issues.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Jay F Rappaport and Xuebin Qin. These partnerships have enriched her research and contributed to her success as an inventor.

Conclusion

Stephani Velasquez exemplifies the spirit of innovation in the biomedical field. Her contributions through her patent and collaborations highlight her commitment to improving health outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…